Real-world evaluation of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors for managing type 2 diabetes mellitus: a retrospective multi-ethnic cohort study

ABSTRACT: PURPOSE: Sodium-glucose co-transporter-2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP4) inhibitors are increasingly used as second-line therapies in patients with type 2 diabetes. The aim of this study was to assess the real-world effects of SGLT2 inhibitors in a multi-ethnic populat...

Descripción completa

Detalles Bibliográficos
Autores principales: Goh, Louise Gek Huang, Sun, Jiandong, Ong, Benjamin Shao Kiat, Khoo, Daphne, Sum, Chee Fang, Ng, Kwong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167339/
https://www.ncbi.nlm.nih.gov/pubmed/35673518
http://dx.doi.org/10.1007/s40200-022-01004-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167339/
https://www.ncbi.nlm.nih.gov/pubmed/35673518
http://dx.doi.org/10.1007/s40200-022-01004-4

Ejemplares similares